Search for: "United States v. Central Pacific R. Co."
Results 41 - 58
of 58
Sort by Relevance
|
Sort by Date
4 Oct 2010, 1:44 am
Sand Hill Advisors, LLC (Seattle Trademark Lawyer) Due diligence matters: E D Washington decision in Pacific Coast Trailers, LLC v. [read post]
2 Aug 2010, 11:15 am
Grace & Co. [read post]
19 Jul 2010, 3:37 pm
The $4 million civil penalty will be divided among the United States, Alabama and Iowa. [read post]
8 Jul 2010, 3:58 am
[Click on citation to access the opinion.]Skilling v United States (Dkt No 08-1394). [read post]
18 May 2010, 1:10 am
Ltd v OHIM, Schwan-Stabilo Schwanhaüßer GmbH & Co. [read post]
10 May 2010, 2:59 am
In addition, the authority of local and state regulatory agencies will be usurped by the U.S. [read post]
15 Apr 2010, 2:19 pm
Rural Telephone Service Co., 499 U.S. 340. [read post]
12 Apr 2010, 10:44 am
Click Here American Trucking Association et al. v. [read post]
7 Apr 2010, 3:44 pm
The two companies will also pay a combined $3.3 million civil penalty to the United States as well as to Alabama and Louisiana, and $200,000 to Louisiana organ [read post]
31 Jan 2010, 7:16 pm
“The United States brought this case to protect an important body of water, Pyramid Lake,” said Ignacia S. [read post]
9 Dec 2009, 5:32 pm
Union Pacific Railroad Co. v. [read post]
9 Dec 2009, 5:32 pm
Union Pacific Railroad Co. v. [read post]
9 Dec 2009, 7:17 am
Also released this week was the United States Supreme Court's decision in Union Pacific R. [read post]
31 Oct 2009, 4:06 pm
In a strongly worded order issued last week, a district judge overturned a 2008 state ruling that granted the authority permission to tap groundwater from three valleys in central Lincoln County. [read post]
27 Jul 2008, 3:27 pm
United States, 116 U. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
18 Dec 2007, 7:42 am
This list was put together by United Cerebral Palsy. [read post]
17 Apr 2007, 11:30 am
Co. (2000) 23 Cal.4th 163. [read post]
